Atlas Trials

A Safety Study Looking at the Combination of Velcade and G-CSF in Patients With Myeloma or Lymphoma

Clinical trial NCT01171092 · COMPLETED

Trial details

NCT number
NCT01171092
Sponsor
University of Kansas Medical Center
Status
COMPLETED
Phase
Early Phase 1
Study type
INTERVENTIONAL
Malignant Lymphoma, Stem Cell TypeAutologous Transplant
Start date
2010-09-01
Primary completion
2013-01-01
Enrollment
21

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.